POLARIS
Country
FranceCity
Pleuven
Address
Chemin de Kilourin 5, 29170
Polaris Group is an international biopharmaceutical company specializing in the development of innovative anti-cancer treatments. Our primary therapeutic candidate, Pegargiminase (ADI?PEG 20), is an advanced biopharmaceutical undergoing late-stage clinical trials for a diverse range of cancers, such as hepatocellular carcinoma, mesothelioma, pancreatic cancer, non-small cell lung cancer, melanoma, acute myeloid leukemia, and others.
Sites
France